Abbott Laboratories
ABT
#101
Rank
NZ$328.95 B
Marketcap
NZ$190.11
Share price
0.79%
Change (1 day)
-14.72%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

EPS for Abbott Laboratories (ABT)

EPS in 2026 (TTM): NZ$6.15

According to Abbott Laboratories's latest financial reports the company's current EPS (TTM) is NZ$6.10. In 2025 the company made an earnings per share (EPS) of NZ$6.34 a decrease over its 2024 EPS that were of NZ$13.07.

EPS history for Abbott Laboratories from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.15-3%
2025NZ$6.34-51.49%
2024NZ$13.07134.51%
2023NZ$5.57-23.23%
2022NZ$7.267.5%
2021NZ$6.7557.41%
2020NZ$4.2921.54%
2019NZ$3.5354.75%
2018NZ$2.28389.07%
2017NZ$0.47-71.01%
2016NZ$1.61-68.01%
2015NZ$5.0396.13%
2014NZ$2.56-8.64%
2013NZ$2.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.76 142.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.87 94.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.21-63.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.32 3.64%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
NZ$30.80 404.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$4.06-33.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$4.11-32.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.02-1.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.75 92.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.57 7.70%๐Ÿ‡ฌ๐Ÿ‡ง UK